Key result
Halving blood lead levels in males is linked to a ~1-mm Hg drop in SBP.
Meta-Analysis
Answers are grounded in this paper and cite their sources.
Animal studies have demonstrated that relatively low doses of lead can produce modest elevations in blood pressure. During the past 10 y, many epidemiologic studies have examined the relationship between low-level lead exposure and blood pressure in humans. These studies were reviewed in a consensus conference, which concluded that the evidence supported the existence of a causal association; however, no formal meta-analysis has been conducted. Epidemiologic studies of blood lead and systolic blood pressure in males were analyzed in the present meta-analysis. A highly significant and moderately consistent association was found, i.e., decrease of blood lead from 10 mg/dl to 5 mg/dl associated with a decrease of 1.25 mm Hg (95% CI = 0.87-1.63 mm Hg). The association was robust to deletion of the most significant study or the addition of eight additional studies showing no effect. Given the strong animal data, which also implicate a mechanism (disturbance of calcium messenger system regulation of blood pressure) present in humans, the association should be considered causal.
No takes yet. Share an insight, caveat, or question.
Joel Schwartz (1995) conducted a meta-analysis in Blood pressure and cardiovascular disease. Blood lead exposure (decrease from 10 mg/dl to 5 mg/dl) vs. Blood lead level of 10 mg/dl was evaluated on Systolic blood pressure (MD -1.25 mm Hg, 95% CI 0.87-1.63). Decreasing blood lead from 10 to 5 mg/dl in males was associated with a 1.25 mm Hg decrease in systolic blood pressure (95% CI 0.87-1.63 mm Hg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: